EAU 2014 - Poster: An economic model to investigate differences in resource utilisation associated with the use of BOTOX® to manage urinary incontinence in patients with idiopathic overactive bladder in the United Kingdom

STOCKHOLM, SWEDEN (UroToday.com) - Presented by C. Loveman,1 J. Millen,1 R. Zeidman,2 and L. Ruff1 at the 29th Annual European Association of Urology (EAU) Congress - April 11 - 15, 2014 - Stockholmsmässan - Stockholm, Sweden.

Poster-582 EAU thumb

1Allergan Limited, Marlow, UK; 2Medaxial Group, London, UK


email news signup